| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |